ate phase II study of NS-304 in patients with intermittent claudication (IC) resulting from arteriosclerosis obliterans (ASO)
Phase 2
Completed
- Conditions
- Arteriosclerosis obliterans (ASO)
- Registration Number
- JPRN-jRCT2080223273
- Lead Sponsor
- ippon Shinyaku Co., Ltd.
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- completed
- Sex
- All
- Target Recruitment
- 342
Inclusion Criteria
Patients with intermittent claudication (IC) resulting from arteriosclerosis obliterans (ASO)
Exclusion Criteria
Patients who have severe ischemia of lower extremities of Stage III or over in Fontaine classification or potentially has severe ischemia of lower extremities
Study & Design
- Study Type
- Interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method efficacy<br>Natural log transformed peak walking time (ln PWT)
- Secondary Outcome Measures
Name Time Method efficacy<br>Natural log transformed claudication onset time (ln COT)